Seven Eight Capital, LP Johnson & Johnson Transaction History

Seven Eight Capital, LP

$0
Q4 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$145.48 - $167.38 $3.07 Million - $3.54 Million	21,128 New	21,128 $3.42 Million
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $1.66 Million - $1.87 Million	10,382 New	10,382 $1.83 Million
Q4 2020 Feb 09, 2021	SELL	$137.11 - $157.38 $1.47 Million - $1.68 Million	-10,700 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $168,456 - $184,596	-1,200 Reduced 10.08%	10,700 $1.59 Million
Q2 2020 Aug 06, 2020	BUY	$128.81 - $155.51 $669,812 - $808,652	5,200 Added 77.61%	11,900 $1.67 Million
Q1 2020 May 14, 2020	BUY	$111.14 - $153.99 $130,700 - $181,092	1,176 Added 21.29%	6,700 $879,000
Q4 2019 Feb 13, 2020	BUY	$127.5 - $146.44 $420,750 - $483,252	3,300 Added 148.38%	5,524 $806,000
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $9.59 Million - $10.7 Million	-75,562 Reduced 97.14%	2,224 $288,000
Q2 2019 Aug 12, 2019	SELL	$131.15 - $144.24 $1.9 Million - $2.09 Million	-14,500 Reduced 15.71%	77,786 $10.8 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $6.4 Million - $7.12 Million	-50,900 Reduced 35.55%	92,286 $12.9 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $17.6 Million - $21.2 Million	143,186 New	143,186 $18.5 Million
Q3 2018 Oct 18, 2018	SELL	$121.58 - $142.88 $1.78 Million - $2.09 Million	-14,600 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$119.4 - $131.76 $1.74 Million - $1.92 Million	14,600 New	14,600 $1.77 Million
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $612,990 - $725,885	-4,900 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$131.22 - $143.62 $682,344 - $746,824	-5,200 Reduced 51.49%	4,900 $685,000
Q3 2017 Oct 16, 2017	BUY	$129.47 - $135.38 $336,622 - $351,988	2,600 Added 34.67%	10,100 $1.31 Million
Q2 2017 Aug 10, 2017	BUY	N/A	7,500	7,500 $992,000

Others Institutions Holding JNJ

# of Institutions

4,512

Shares Held

1.73B

Call Options Held

16.8M

Put Options Held

13.9M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $428B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Account